- Home
- MPU vs FBRX Comparison
MPU vs FBRX Comparison
Compare MPU & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- FBRX
- Stock Information
- Founded
- MPU 1989
- FBRX N/A
- Country
- MPU Singapore
- FBRX United States
- Employees
- MPU N/A
- FBRX N/A
- Industry
- MPU Transportation Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- FBRX Health Care
- Exchange
- MPU Nasdaq
- FBRX Nasdaq
- Market Cap
- MPU 40.0M
- FBRX 35.3M
- IPO Year
- MPU 1998
- FBRX N/A
- Fundamental
- Price
- MPU $0.92
- FBRX $7.84
- Analyst Decision
- MPU
- FBRX Strong Buy
- Analyst Count
- MPU 0
- FBRX 3
- Target Price
- MPU N/A
- FBRX $80.50
- AVG Volume (30 Days)
- MPU 46.9K
- FBRX 23.3K
- Earning Date
- MPU 05-20-2025
- FBRX 05-27-2025
- Dividend Yield
- MPU N/A
- FBRX N/A
- EPS Growth
- MPU N/A
- FBRX N/A
- EPS
- MPU N/A
- FBRX N/A
- Revenue
- MPU $36,184,000.00
- FBRX N/A
- Revenue This Year
- MPU N/A
- FBRX N/A
- Revenue Next Year
- MPU N/A
- FBRX N/A
- P/E Ratio
- MPU N/A
- FBRX N/A
- Revenue Growth
- MPU N/A
- FBRX N/A
- 52 Week Low
- MPU $0.49
- FBRX $4.11
- 52 Week High
- MPU $2.57
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- MPU 54.50
- FBRX 60.08
- Support Level
- MPU $0.72
- FBRX $6.20
- Resistance Level
- MPU $0.98
- FBRX $6.91
- Average True Range (ATR)
- MPU 0.08
- FBRX 0.59
- MACD
- MPU -0.00
- FBRX 0.14
- Stochastic Oscillator
- MPU 71.46
- FBRX 87.24
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).